Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309984 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01309984 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 10 participants.
The verdict
NCT01309984, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the transfer of fospropofol and its active metabolite, propofol, to breast milk following administration of LUSEDRA® to lactating women undergoing a needed procedure.
Interventions
- DRUG Propofol
- DRUG Lusedra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01309984
The ClinicalTrials.gov registry entry for NCT01309984 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT01309984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01309984 about?
NCT01309984 is a clinical study titled "A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure". The purpose of this study is to assess the transfer of fospropofol and its active metabolite, propofol, to breast milk following administration of LUSEDRA® to lactating women undergoing a needed procedure.
What is the current status of trial NCT01309984?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2010-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01309984?
The interventions under investigation include: Propofol (DRUG), Lusedra (DRUG).
Who is sponsoring clinical trial NCT01309984?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.